$MTVA leads the PRISM Emerging Weight Loss Index, up 18% on Q1 2025 news! Positive Phase 1 results for DA-1726 show powerful weight loss, glucose control, and tolerability—positioning it as a best-in-class obesity treatment.
#MetaVia #PRISMEmergingWeightLossIndex